Top Immunotherapy Hospitals in India | Cancer Treatment

Install App For Better User Experience

Best Immunotherapy Hospitals in India

Immunotherapy in India represents significant advancements in the cancer domain. It is one of the most promising emerging treatments transforming the prognosis for several patients. Leveraging your immune system for targeting and destroying cancerous cells, immunotherapy provides durable remission and improved rates of survival across a variety of malignancies. With the rising global awareness of immunotherapy, India has been positioning itself at the forefront of this medical transformation. 

List of Best Hospitals Offering Immunotherapy in India

With immunotherapy continuing to redefine the future of cancer research and care worldwide, India’s top Immunotherapy hospitals stand out from the crowd. These Immunotherapy hospitals are pivotal in innovation and centers of excellence. With their life-changing therapies and treatments, the hospitals stand as a ray of hope for patients seeking advanced cancer care. 

Apollo Proton Cancer Centre (APCC), Chennai

Number of Beds: 150+
Established in: 2019
Apollo Proton Cancer Centre (APCC) is among a few best facility offering proton therapy in India. It is recognized for its phenomenal contribution to the field of oncology. It has state-of-the-art technology, advanced immunotherapy, including proton beam therapy, and molecular diagnostics. APCC is equipped with internationally trained oncologists, a robust research team, and specialized nursing staff. Services: Molecular tumor profiling, Monoclonal antibody therapies, Integrated care with proton therapy, Investigational immunotherapeutics, Biomarker-based therapy selection, Immune checkpoint inhibitors (PD-1/PD-L1, CTLA-4 blockers) See more
Chennai, Tamil Nadu

Tata Memorial Hospital, Mumbai

Tata Memorial Hospital, MumbaiComprehensive Cancer Care
Number of Beds: 800+
Established in: 1941
Tata Memorial Hospital is the largest and most renowned cancer treatment center in India. It is popular for its affordable and high-quality cancer care for all socio-economic groups. The hospital deals with an enormous patient load and is involved in extensive research across cancer domains. It offers a complete spectrum of cancer therapies, including immunotherapy, through its multidisciplinary approach. It has popular global research collaborations, too. Services: Standard-of-care immune checkpoint inhibitors, CAR T-cell therapy, Monoclonal antibody infusions for lymphoma, leukemia, breast, and colorectal cancers, Cancer vaccines, Cytokine-based immunotherapies, Adoptive cell therapies, Comprehensive molecular diagnostic therapies See more
Mumbai, Maharashtra

Max Super Specialty Hospital, Saket, New Delhi

Max Super Specialty Hospital, Saket, New DelhiAdvanced Oncology & Immunotherapy
Number of Beds: 500+
Established in: 2006
Max Super Specialty Hospital in Saket, New Delhi is a NABH and JCI-accredited tertiary cancer care centre. It is home to one of India's leading oncology departments. It offers advanced immunotherapy programs for a comprehensive framework of cancer care and research. The program at Max Super Speciality Hospital emphasises strongly on evidence-based protocols and precision medicines. Services: FDA-approved checkpoint inhibitors for lung, bladder, head & neck, Immunotherapy-chemotherapy/radiation, Precision oncology, Genetic and molecular testing for immunotherapy suitability, Participation in multicenter clinical trials, Patient-tailored dosing, monitoring, and management of immune-related side effects, Monoclonal antibody treatments See more
Saket, New Delhi

    Share Your Concerns

    Medanta – The Medicity, Gurugram

    Medanta – The Medicity, GurugramMulti-Specialty & Oncology Research
    Number of Beds: 1250
    Established in: 2009
    The Medanta, Gurugram, is a multispeciality hospital offering super-tertiary care. The hospital is acclaimed for its innovative oncology department. It leverages diagnosis for molecular and genetic care to support its cutting-edge research in immunotherapy and targeted cancer cell therapies. The cancer research and care team at Medanta is composed of globally respected specialists who offer a holistic ecosystem. Services: Checkpoint inhibitors (PD-1/PD-L1, CTLA-4), Combination immunotherapy, Targeted therapy approaches, Monoclonal antibody infusions, Comprehensive immune profiling, Biomarker testing, CAR T-cell therapy See more
    Gurugram, Haryana

    Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), New Delhi

    Number of Beds: 500+
    Established in: 1996
    Rajiv Gandhi Cancer Institute and Research Centre is the largest and most advanced cancer care and research hospital in India. It is focused on specialized oncology research and holistic patient care. The hospital is engaged in offering comprehensive cancer management programs related to surgeries, diagnostics, chemotherapy, and leading-edge immunotherapy. It has a firm grip in clinical trials and translational research. The hospital is dedicated to bringing the latest global innovations for patients in India. Services: Immune checkpoint blockers, Monoclonal antibodies, Bispecific antibody infusions, CAR T-cell therapy research programs, Cancer vaccine programs, Advanced immune monitoring, Molecular stratification of patients, Adoptive cell therapy for relapsed/refractory See more
    Rohini, New Delhi

    Apollo Cancer Centre, Kolkata

    Apollo Cancer Centre, KolkataOncology & Precision Medicine
    Number of Beds: 100+
    Established in: 2010
    Apollo Cancer Centre in Kolkata offers a one-stop destination for comprehensive care in oncology. The hospital provides a combined holistic care for advanced immunotherapy and targeted treatment regimens. It is equipped with the latest diagnostics, minimally invasive surgeries, and precision medicines. The medical professional team here is highly qualified, with oncologists tailoring treatments for every cancer type. The hospital is renowned for its compassionate healing approach and patient educational initiatives. Services: Use of checkpoint inhibitors, Molecular testing using PD-L1/deficiency, NGS panels, Monoclonal antibody-based treatments, Multi-modality cancer protocols based on treatment regimens See more
    Kolkata, West Bengal

    Artemis Hospital, Gurugram

    Artemis Hospital, GurugramAdvanced Immunotherapy & Diagnostics
    Number of Beds: 750+
    Established in: 2007
    Artemis Hospital in Gurugram, Haryana, is both NABH and JCI-accredited. This multi-speciality hospital is renowned for its innovation and clinical excellence. The Cancer Center of this hospital brings together the latest cutting-edge technology in immunotherapy, molecular diagnostics, and digital pathology. It is committed to patient-centric multidisciplinary care to offer individualized immunotherapy regimens. Services: Immune checkpoint inhibitor therapy, Monoclonal antibody treatments, Personalized immunotherapy plans, Next-generation sequencing See more
    Gurugram, Haryana

    HCG Cancer Centre, Bengaluru

    HCG Cancer Centre, BengaluruCancer Specialty Network Hospital
    Number of Beds: 300+
    Established in: 2007
    HealthCare Global (HCG) Cancer Centre in Bengaluru is a leading nationwide network of cancer specialty hospitals. The hospital champions the latest protocols of cancer research and treatment. It is popular for its integrated approach of combining traditional cancer therapies with modern immunotherapy. Specialized multidisciplinary tumor boards back the hospital. It is also a popular centre featuring advanced diagnostics and clinical research. The hospital offers an intense rehabilitation program for cancer survivors. Services: Full array of immune checkpoint inhibitors, Monoclonal antibody therapies, Combination chemotherapies, Targeted therapies with immune agents, Tumor mutational profiling, Predictive biomarker testing, Clinical research in CAR T-cell, Advanced adoptive cell therapies See more
    Bengaluru, Karnataka

    Fortis Memorial Research Institute (FMRI), Gurugram

    Number of Beds: 330+
    Established in: 2013
    Fortis Memorial Research Institute (FMRI) is a renowned super-speciality cancer care and research hospital. It is home to a leading oncology centre and its cancer department integrates world-class surgical, medical, and radiation oncology. It is recognized for providing personalized immunotherapy solutions based on genomics and molecular tumor profiling. Services: Monoclonal antibody infusions, Biotherapy-specific clinics, Comprehensive patient assessment, Advanced immune modulation trials, Robust patient monitoring with digital health, Immune checkpoint inhibitors See more
    Gurugram, Haryana

    Amrita Institute of Medical Sciences (Amrita Hospital), Kochi

    Number of Beds: 1300+
    Established in: 1998
    Amrita Hospital of Kolkata is one of the largest super-speciality hospitals across South Asia. It combines academic excellence with quality research and patient care. A robust research wing and multidisciplinary tumor boards back the onco-immunology program offered here. It ensures access to treatment options such as immunotherapy and next-generation sequencing. Services: Immune checkpoint inhibitors for lung, melanoma, kidney, and other cancer treatments, Monoclonal antibodies, Cancer immunomodulators, Pediatric and adult immunotherapies, Cell-based therapies, Molecular and genetic profiling for treatment, Post-immunotherapy survivorship and rehabilitation programs See more
    Kochi, Kerala

    There are several leading Immunotherapy hospitals contributing significant investments across cutting-edge infrastructure and research, with clinical expertise tailored around immuno-oncology. Indian hospitals now offer a comprehensive range of the best immunotherapy treatments: 

    • Immune Checkpoint Inhibitors: They target molecules like PD-1, PD-L1, and CTLA-4 to “remove the brakes” from the immune system, allowing it to attack cancer cells. These are approved for a wide array of cancers, including lung, melanoma, kidney, head and neck, gastric, and bladder cancers.
    • CAR T-cell Therapy: An advanced and highly personalized therapy where a patient’s T-cells are genetically modified to target cancer cells. This is available at select top centers and is usually offered for certain leukemias and lymphomas.
    • Monoclonal Antibodies: Laboratory-produced antibodies are designed to bind to specific antigens on cancer cells, either marking them for immune destruction or blocking their growth.
    • Cancer Vaccines: Both preventive and therapeutic vaccines are being explored, some as part of clinical trials, aimed at priming the immune system to recognize and eliminate cancer cells.
    • Adoptive Cell Transfer: Techniques like tumor-infiltrating lymphocyte (TIL) therapy are available in select research settings, harvesting and expanding a patient’s immune cells to attack the tumor more effectively.
    • Combination Immunotherapy: Many patients benefit from immunotherapies combined with chemotherapy, targeted therapies, or radiation, improving response rates and survival.

    Why Choose Immunotherapy in India?

    India is rapidly emerging as a global leader in the domain of oncology, with several world-renowned cancer treatment hospitals. These hospitals are equipped with the latest and advanced state-of-the-art immunotherapy. Many of the best immunotherapy hospitals in India are NABH, NABL, and JCI-accredited. These accreditations ensure that patients receive care that meets the highest global standards for safety, quality, and outcomes.

    Indian immunotherapy hospitals are leading the latest advances in the immunotherapy domain. To list a few of the services available, here are immune checkpoint inhibitors, monoclonal antibodies, cancer vaccines, and CAR T-cell therapy. The affordability of these treatment options in India is at a fraction of the price as compared to the services available across North America, Europe, or Australia. It is this cost-effectiveness that international patients seek quality healthcare services in India.

    The cancer centers in India for Immunotherapy emphasize the concepts of molecular diagnostics and personalized medicine. These Immunotherapy hospitals are well equipped with advanced technologies such as sophisticated testing for PD-L1, MSI status, NGS (next-generation sequencing), and other biomarkers. Availability of these services enables oncologists to tailor immunotherapy regimens personalized to each patient’s requirements. 

    How Cancer Rounds Can Support Your Immunotherapy Journey in India?

    • Personalized Treatment Planning – We begin by understanding your unique medical history and condition. Our team collaborates with leading doctors to develop a tailored treatment plan that aligns with your specific needs and preferences.
    • Cost Estimates and Financial Guidance – Understanding the financial aspects of treatment is crucial. We provide transparent cost estimates for immunotherapy across various hospitals in India, helping you make informed decisions that suit your budget.
    • Hospital Selection and Comparison – Choosing the right hospital is vital for successful treatment. We offer detailed comparisons of top hospitals offering immunotherapy
    • Medical Visa Assistance – For international patients, we provide comprehensive support in obtaining medical visas, ensuring a hassle-free process. Our team assists with documentation, appointment letters, and liaises with Indian embassies to facilitate timely approvals.

    Frequently Asked Questions (FAQs) about Immunotherapy in India

    Q1. What types of cancer can Immunotherapy treat in India?

    The best immunotherapy hospitals in India are equipped to treat the following cancer types with immunotherapy:

    Q2. Who is eligible for Immunotherapy in India?

    The eligibility criteria for immunotherapy in India are based on several factors for patients such as:

    • Cancer Type & Stage: It is primarily given for certain advanced, metastatic, or recurrent cancers 
    • Biomarkers: Testing for markers like microsatellite instability (MSI), PD-L1 expression, or mismatch repair (MMR) status, and sometimes next-generation sequencing 
    • Previous Treatments: Patients not responding well to surgeries, chemotherapy, and radiation treatments 
    • General Health: Patients having issues with routine organ functioning, such as the liver, kidney, and heart, may not be eligible to tolerate the potential side effects of immunotherapy. 
    • Other Factors: Contraindications such as uncontrolled infections or autoimmune disorders may impact your eligibility for immunotherapy. 
    • Consultation Requirement: You should have a detailed discussion with your oncologist to reconsider your eligibility to undergo immunotherapy. 

    Q3. What are the potential side effects of Immunotherapy?

    The common side effects, as outlined by the best immunotherapy hospitals in India, are:

    • Common Side Effects: Fatigue, skin rash, itching, flu-like symptoms, colitis, diarrhea, and appetite loss. 
    • Immune-Related Adverse Events
    • Cytokine Release Syndrome (CRS): Low blood pressure, sudden fever, and difficulty in breathing 
    • Neurotoxicity: Seizures, confusion, cognitive transformations
    • Endocrine Gland Issues: Hypophysitis and thyroiditis
    • Pneumonitis: Lung inflammation 
    • Hepatitis: Elevated levels of liver enzymes 

    Q4. How long does the Immunotherapy process take?

    Typically, the entire process of immunotherapy will take around 2-4 weeks. Every 2-4 weeks, you will be called upon to undergo intravenous infusion, with each session lasting for hours. Some regimens may take as long as 6-8 months. Some may even go beyond 2 years, especially if your cancer is responding and your body is tolerating the treatment. Your oncologist will ask you to undergo scans and blood tests every 2-3 months to check your response to the treatment. 

    Q5. What is the success rate of Immunotherapy in India?

    The success rate of immunotherapy treatment regimens in India varies significantly by cancer type. Typically, the success rates are:

    • In advanced melanoma or Hodgkin’s lymphoma: 40-60%
    • In non-small cell lung cancer (with high PD-L1): 25-45%
    • In MSI-high colorectal cancer: ~40%

    Our Impact

    CancerRounds is making quality cancer care accessible to more people every day.

    Send your reports
    700+ Oncology Specialists
    Send your reports
    75+ Partner Hospitals
    Send your reports
    10000+ Patients Served
    Send your reports
    98% Patient Satisfaction

    Why Choose India for Cancer Treatment?

    World-Class Care

    World-Class Care

    Skilled oncologists provide top-tier medical services

    Affordable Treatment

    Affordable Treatment

    Costs are significantly lower than in Western countries.

    Comprehensive Packages

    Comprehensive Packages

    Hospitals offer all-inclusive plans covering surgery, stay, and aftercare.

    Easy Accessibility

    Easy Accessibility

    Well-connected airports and international flight routes.

    Proven Success

    Proven Success

    High patient satisfaction and positive treatment outcomes

      Get in touch

      User
      City
      Message
      Whatsapp Us Chat